BioPorto (BIOPOR) - Net Assets

Latest as of December 2025: Dkr63.01 Million DKK ≈ $9.86 Million USD

Based on the latest financial reports, BioPorto (BIOPOR) has net assets worth Dkr63.01 Million DKK (≈ $9.86 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr93.18 Million ≈ $14.58 Million USD) and total liabilities (Dkr30.17 Million ≈ $4.72 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore BIOPOR total asset value for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Dkr63.01 Million
% of Total Assets	67.62%
Annual Growth Rate	N/A
5-Year Change	37.08%
10-Year Change	42.26%
Growth Volatility	90.38

BioPorto - Net Assets Trend (1999–2025)

This chart illustrates how BioPorto's net assets have evolved over time, based on quarterly financial data. Check BIOPOR tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Annual Net Assets for BioPorto (1999–2025)

The table below shows the annual net assets of BioPorto from 1999 to 2025. For live valuation and market cap data, see BioPorto market capitalisation.

Year	Net Assets	Change
2025-12-31	Dkr63.01 Million ≈ $9.86 Million	-7.04%
2024-12-31	Dkr67.78 Million ≈ $10.60 Million	+12.66%
2023-12-31	Dkr60.16 Million ≈ $9.41 Million	-14.33%
2022-12-31	Dkr70.22 Million ≈ $10.99 Million	+52.77%
2021-12-31	Dkr45.96 Million ≈ $7.19 Million	-54.45%
2020-12-31	Dkr100.91 Million ≈ $15.79 Million	+298.52%
2019-12-31	Dkr25.32 Million ≈ $3.96 Million	-54.94%
2018-12-31	Dkr56.20 Million ≈ $8.79 Million	+0.23%
2017-12-31	Dkr56.07 Million ≈ $8.77 Million	+26.59%
2016-12-31	Dkr44.29 Million ≈ $6.93 Million	-0.44%
2015-12-31	Dkr44.48 Million ≈ $6.96 Million	+55.08%
2014-12-31	Dkr28.69 Million ≈ $4.49 Million	-33.07%
2013-12-31	Dkr42.86 Million ≈ $6.71 Million	+3827.13%
2012-12-31	Dkr-1.15 Million ≈ $-179.93K	-129.19%
2011-12-31	Dkr3.94 Million ≈ $616.44K	+19.07%
2010-12-31	Dkr3.31 Million ≈ $517.72K	-78.53%
2009-12-31	Dkr15.41 Million ≈ $2.41 Million	-0.59%
2008-12-31	Dkr15.50 Million ≈ $2.43 Million	-47.37%
2007-12-31	Dkr29.45 Million ≈ $4.61 Million	+267.21%
2006-12-31	Dkr-17.62 Million ≈ $-2.76 Million	-476.44%
2005-12-31	Dkr-3.06 Million ≈ $-478.13K	-104.56%
2004-12-31	Dkr66.97 Million ≈ $10.48 Million	+0.59%
2003-12-31	Dkr66.58 Million ≈ $10.42 Million	+3151.10%
2002-12-31	Dkr-2.18 Million ≈ $-341.39K	-293.15%
2001-12-31	Dkr-555.00K ≈ $-86.83K	-162.08%
2000-12-31	Dkr894.00K ≈ $139.87K	+418.15%
1999-12-31	Dkr-281.00K ≈ $-43.96K	--

Equity Component Analysis

This analysis shows how different components contribute to BioPorto's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 43332400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Dkr495.11 Million	785.78%
Other Comprehensive Income	Dkr1.22 Million	1.94%
Total Equity	Dkr63.01 Million	100.00%

BioPorto Competitors by Market Cap

The table below lists competitors of BioPorto ranked by their market capitalization.

Company	Market Cap
Opal Balance TA:OPAL	$91.03 Million
Q32 Bio Inc NASDAQ:QTTB	$91.06 Million
The Platform Group AG XETRA:TPG	$91.08 Million
Ilyang Pharmaceutical Co Ltd KO:007575	$91.10 Million
GMM Grammy Public Company Limited BK:GRAMMY	$90.98 Million
KHD Humboldt Wedag International AG XETRA:KWG	$90.96 Million
Rithm Property Trust Inc. NYSE:RPT	$90.95 Million
Nestcon Bhd KLSE:0235	$90.95 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in BioPorto's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 67,778,000 to 63,009,000, a change of -4,769,000 (-7.0%).
Net loss of 82,117,000 reduced equity.
New share issuances of 76,855,000 increased equity.
Other comprehensive income increased equity by 2,276,000.
Other factors decreased equity by 1,783,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Dkr-82.12 Million	-130.33%
Share Issuances	Dkr76.86 Million	+121.97%
Other Comprehensive Income	Dkr2.28 Million	+3.61%
Other Changes	Dkr-1.78 Million	-2.83%
Total Change	Dkr-	-7.04%

Book Value vs Market Value Analysis

This analysis compares BioPorto's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 10.02x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-12-31	Dkr-0.08	Dkr1.18	x
2006-12-31	Dkr-0.43	Dkr1.18	x
2007-12-31	Dkr0.56	Dkr1.18	x
2008-12-31	Dkr0.24	Dkr1.18	x
2009-12-31	Dkr0.24	Dkr1.18	x
2010-12-31	Dkr0.05	Dkr1.18	x
2011-12-31	Dkr0.05	Dkr1.18	x
2012-12-31	Dkr-0.02	Dkr1.18	x
2013-12-31	Dkr0.43	Dkr1.18	x
2014-12-31	Dkr0.19	Dkr1.18	x
2015-12-31	Dkr0.29	Dkr1.18	x
2016-12-31	Dkr0.27	Dkr1.18	x
2017-12-31	Dkr0.31	Dkr1.18	x
2018-12-31	Dkr0.28	Dkr1.18	x
2019-12-31	Dkr0.10	Dkr1.18	x
2020-12-31	Dkr0.47	Dkr1.18	x
2021-12-31	Dkr0.17	Dkr1.18	x
2022-12-31	Dkr0.21	Dkr1.18	x
2023-12-31	Dkr0.17	Dkr1.18	x
2024-12-31	Dkr0.17	Dkr1.18	x
2025-12-31	Dkr0.12	Dkr1.18	x

Capital Efficiency Dashboard

This dashboard shows how efficiently BioPorto utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -130.33%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -203.83%
• Asset Turnover: 0.43x
• Equity Multiplier: 1.48x
Recent ROE (-130.33%) is below the historical average (-102.07%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2004	0.16%	4.99%	0.03x	1.21x	Dkr-6.59 Million
2005	0.00%	-360.20%	0.30x	0.00x	Dkr-15.41 Million
2006	0.00%	-305.82%	1.16x	0.00x	Dkr-15.22 Million
2007	-51.76%	-182.81%	0.25x	1.15x	Dkr-18.19 Million
2008	-92.01%	-171.03%	0.44x	1.24x	Dkr-15.81 Million
2009	-104.33%	-146.06%	0.54x	1.31x	Dkr-17.62 Million
2010	-432.15%	-103.61%	0.66x	6.34x	Dkr-14.63 Million
2011	-378.32%	-80.21%	0.87x	5.39x	Dkr-15.30 Million
2012	0.00%	-82.32%	0.98x	0.00x	Dkr-14.59 Million
2013	-48.11%	-124.05%	0.32x	1.21x	Dkr-24.91 Million
2014	-45.06%	-69.10%	0.50x	1.30x	Dkr-15.79 Million
2015	-24.12%	-52.65%	0.42x	1.10x	Dkr-15.18 Million
2016	-51.48%	-110.04%	0.41x	1.14x	Dkr-27.23 Million
2017	-57.51%	-128.18%	0.38x	1.17x	Dkr-37.85 Million
2018	-67.70%	-146.25%	0.39x	1.18x	Dkr-43.67 Million
2019	-275.03%	-261.60%	0.62x	1.69x	Dkr-72.17 Million
2020	-61.01%	-265.31%	0.17x	1.39x	Dkr-71.65 Million
2021	-124.26%	-235.48%	0.30x	1.77x	Dkr-61.71 Million
2022	-108.12%	-262.08%	0.27x	1.55x	Dkr-82.95 Million
2023	-93.63%	-181.95%	0.34x	1.49x	Dkr-62.34 Million
2024	-100.69%	-188.29%	0.38x	1.42x	Dkr-75.02 Million
2025	-130.33%	-203.83%	0.43x	1.48x	Dkr-88.42 Million

Industry Comparison

This section compares BioPorto's net assets metrics with peer companies in the Diagnostics & Research industry.

No peer company data available for comparison.

About BioPorto

CO:BIOPOR Denmark Diagnostics & Research

Market Cap

$91.02 Million

Dkr581.74 Million DKK

Market Cap Rank

#19513 Global

#84 in Denmark

Share Price

Dkr1.18

Change (1 day)

-1.26%

52-Week Range

Dkr0.84 - Dkr1.44

All Time High

Dkr7.78